<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/xsl" href="https://www.taxtmi.com/rss_sitemap/rss_feed_blog.xsl?v=1750492856"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>Tribunal Finds No Evidence to Support Claim of Diverted Funds in Ranbaxy Non-Compete Agreement Case.</title>
    <link>https://www.taxtmi.com/highlights?id=38261</link>
    <description>Non-competition agreement with Ranbaxy Laboratories Ltd. - nature of receipt - Though a vague finding was rendered that the amount which was otherwise receivable by the company was diverted by the appellant, the same was not substantiated by the Tribunal - in the absence of a finding that the two agreements entered with RLL and SPIL are sham and nominal, no addition can be made - HC</description>
    <language>en-us</language>
    <pubDate>Thu, 08 Mar 2018 17:25:25 +0530</pubDate>
    <lastBuildDate>Thu, 08 Mar 2018 17:25:25 +0530</lastBuildDate>
    <generator>TaxTMI RSS Generator</generator>
    <atom:link href="https://www.taxtmi.com/rss_feed_blog?id=511847" rel="self" type="application/rss+xml"/>
    <item>
      <title>Tribunal Finds No Evidence to Support Claim of Diverted Funds in Ranbaxy Non-Compete Agreement Case.</title>
      <link>https://www.taxtmi.com/highlights?id=38261</link>
      <description>Non-competition agreement with Ranbaxy Laboratories Ltd. - nature of receipt - Though a vague finding was rendered that the amount which was otherwise receivable by the company was diverted by the appellant, the same was not substantiated by the Tribunal - in the absence of a finding that the two agreements entered with RLL and SPIL are sham and nominal, no addition can be made - HC</description>
      <category>Highlights</category>
      <law>Income Tax</law>
      <pubDate>Thu, 08 Mar 2018 17:25:25 +0530</pubDate>
      <guid isPermaLink="true">https://www.taxtmi.com/highlights?id=38261</guid>
    </item>
  </channel>
</rss>